about
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterolAutosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH geneMolecular diagnosis of hypobetalipoproteinemia: an ENID reviewExome sequencing in suspected monogenic dyslipidemias.Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemiaLipid peroxidation, nitric oxide metabolites, and their ratio in a group of subjects with metabolic syndrome.Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia.Food intolerance and chronic constipation: manometry and histology study.Multiple food hypersensitivity as a cause of refractory chronic constipation in adults.Lipase maturation factor 1 is required for endothelial lipase activity.SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-αThe atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population.Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis.A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia.A novel component of the metabolic syndrome: the oxidative stress.Clinical utility of novel biomarkers for cardiovascular disease risk stratification.Beyond statins: new lipid lowering strategies to reduce cardiovascular risk.Homozygous familial hypobetalipoproteinemia: two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature.The pathophysiology of intestinal lipoprotein production.C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells.Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project.Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction.The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation.Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia.Lipid and apoprotein behaviour after oral fat load in hypertriglyceridaemia.Leukocyte count, diabetes mellitus and age are strong predictors of stroke in a rural population in southern Italy: an 8-year follow-up.Carotid atherosclerosis in hypercholesterolemic patients: relationship with cardiovascular events.Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study.Italian familial defective apolipoprotein B patients share a unique haplotype with other Caucasian patients.Nutritional characteristics of a rural Southern Italy population: the Ventimiglia di Sicilia Project.Differential apolipoprotein(a) isoform expression in heterozygosity is an independent contributor to lipoprotein(a) levels variability.The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction.Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity.Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia.Oxidative status in nondiabetic middle-aged subjects with metabolic syndrome: preliminary data.Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles.[Plasma lipids and apoproteins. The effect of cigarette smoking]Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia.Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia.
P50
Q24336810-242433F8-76D9-42DB-9346-19E7C8E98FF7Q28204109-0F9B64A9-7B04-4D3B-BFAE-350034D49799Q28306392-2EC54F86-95E6-45AF-8DCC-6D1A3A72DE69Q30405700-6E1AAA22-6EE7-42A5-96C5-51B5095FC5B3Q33644452-34A38A9E-E039-4F4A-9D98-1360A4C25FC7Q33765378-80E992DC-4AE0-494D-8D01-AE2DD343E87AQ34453670-42575349-A1A5-48A1-85AB-04AA23E64EF6Q34481983-D5F219B0-CEF1-4B28-996A-69479A77981CQ34517145-897714E1-EC7D-43EA-B5EF-F3F7C2EF238FQ34955884-55BEB2B7-21EA-4009-A5EC-20039598CD62Q36293021-97AEABB9-BE47-4BF2-9FCD-033F480B02C9Q37106593-6101ABAA-592A-465A-910D-DA3B31DD087FQ37305417-B31EC948-D53C-42C0-8409-A68B6D1AFDE2Q37408477-C713DD9F-16A9-4E4A-9955-A7155CD516BEQ37595771-44061F2A-D678-4E96-B276-A07A961EC686Q38052852-BE4C5CF7-D84F-4FC3-B7A8-9F5DF4A79A13Q38207925-A10B8F6B-C593-42BE-9443-8866F628CE57Q38330970-ED2C85DD-257E-481E-9C10-DCE97668603EQ38410893-86886814-1123-4BA0-9D2C-C3820EA4BFBFQ39949238-057D4A5D-5318-491A-B2A1-9FAA967B7357Q40377361-B8D2F03B-A181-4467-9F0A-87FE97F84D21Q40602410-9C96F8FE-3AF6-45F2-8643-B685F6B8A845Q42164977-CB8CBA2A-A7D4-4D28-A2C2-7E6124F12811Q42977998-120BEB7B-A26E-4A45-9735-FEA97A62CC91Q43187323-D335B2C8-EA7B-4F94-AF8B-7D44B2FA2DB3Q43587144-6D1403C0-877F-4B7D-B29C-C1EA3A1D7125Q43654241-E9FF676B-63DE-4441-A691-64EBDB5261ADQ43659276-3C8F53C0-D067-46D8-BD17-F4CDC7A58442Q43815032-E4726C30-7E4A-4F8E-8F10-77E3D8CD2437Q43880045-A91AD116-2579-45F5-955B-A56405C9335AQ44248131-D64E7B68-9C49-49E4-A7F7-B90B664EBFF8Q44297697-3CF728D7-26B6-4062-BB4B-C4E9B0F50D19Q44675516-0EB2730A-8BA9-4DA0-868B-C6C27BAD85C2Q44931968-4595FAEE-E1C8-46DC-9567-2BF0AA46B780Q45025235-9AF57D90-921A-487B-9BA1-C74BA4C6B136Q45354590-8FD4011D-6B25-40F7-AF3C-89D8D769A846Q45924780-8194B5DC-0367-46AB-89B5-2505F6C4ADBAQ45970542-09F326C5-1CB0-4DA9-B132-61A9D023C024Q46062174-109C68CA-15C5-4258-AD41-67F7FB05D6D1Q46313108-8F1C8BC1-EF37-4148-A8DD-BC5A930CCF0E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Davide Noto
@ast
Davide Noto
@en
Davide Noto
@es
Davide Noto
@nl
Davide Noto
@sl
type
label
Davide Noto
@ast
Davide Noto
@en
Davide Noto
@es
Davide Noto
@nl
Davide Noto
@sl
prefLabel
Davide Noto
@ast
Davide Noto
@en
Davide Noto
@es
Davide Noto
@nl
Davide Noto
@sl
P106
P1153
6701558266
P21
P31
P496
0000-0002-5346-2829